We are live on ! Find out more
LGND icon

Ligand Pharmaceuticals
LGND

357 hedge funds and large institutions have $4.15B invested in Ligand Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 133 increasing their positions, 115 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 43

22% more call options, than puts

Call options by funds: $8.48M | Put options by funds: $6.95M

16% more repeat investments, than reductions

Existing positions increased: 133 | Existing positions reduced: 115

7% more capital invested

Capital invested by funds: $3.89B → $4.15B (+$264M)

2% more funds holding

Funds holding: 349 → 357 (+8)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

0.18% less ownership

Funds ownership: 104.47% → 104.29% (-0.18%)

Holders
357
Holders Change
+8
Holders Change %
+2.29%
% of All Funds
4.39%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
59
Increased
133
Reduced
115
Closed
43
Calls
$8.48M
Puts
$6.95M
Net Calls
+$1.54M
Net Calls Change
-$3.42M

Top Buyers

1
Invesco
Invesco
Georgia
+$60.8M
2
NCGI
Next Century Growth Investors
Minnesota
+$19M
3
Bessemer Group
Bessemer Group
New Jersey
+$16.7M
4
Franklin Resources
Franklin Resources
California
+$15.2M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$12.9M

Top Sellers

1
UBS AM
UBS AM
Illinois
-$29.8M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$21M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$18.9M
4
NAMI
Nomura Asset Management International
Pennsylvania
-$14M
5
Goldman Sachs
Goldman Sachs
New York
-$9.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
151
Gibbs Wealth Management
Georgia
$1.11M +$438K +2,215 +66%
Fifth Third Bancorp
152
Fifth Third Bancorp
Ohio
$1.1M +$1.06M +5,349 +3,519%
ASRS
153
Arizona State Retirement System
Arizona
$1.08M -$19.6K -99 -2%
YCM
154
Yousif Capital Management
Michigan
$1.07M -$7.72K -39 -0.7%
ACM
155
Aquatic Capital Management
Illinois
$1.06M +$1.05M +5,294 New
PFSRSONJ
156
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.04M – – –
Los Angeles Capital Management
157
Los Angeles Capital Management
California
$1.03M -$1.02M -5,171 -50%
ET
158
Equitable Trust
Tennessee
$1.01M – – –
Connor, Clark & Lunn Investment Management (CC&L)
159
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$987K -$216K -1,090 -18%
COPPSERS
160
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$972K -$1.19K -6 -0.1%
VIA
161
Vanguard Investments Australia
Australia
$959K +$950K +4,802 New
TRSOTSOK
162
Teachers Retirement System of the State of Kentucky
Kentucky
$957K – – –
KK
163
KLP Kapitalforvaltning
Norway
$938K +$98.9K +500 +12%
VA
164
Vident Advisory
Georgia
$927K +$919K +4,645 New
OPERF
165
Oregon Public Employees Retirement Fund
Oregon
$898K +$2.97K +15 +0.3%
SPC
166
Sigma Planning Corp
Michigan
$898K +$297K +1,500 +50%
VIA
167
Virtus Investment Advisers
Connecticut
$889K +$168K +848 +24%
AI
168
Atria Investments
North Carolina
$881K +$88.4K +447 +11%
State of Tennessee, Department of Treasury
169
State of Tennessee, Department of Treasury
Tennessee
$874K -$146K -740 -14%
Cetera Investment Advisers
170
Cetera Investment Advisers
Illinois
$850K +$183K +924 +28%
GAM
171
Gotham Asset Management
New York
$833K -$1.02M -5,174 -55%
EAM
172
Erste Asset Management
Austria
$828K – – –
GT
173
Glenmede Trust
Pennsylvania
$809K -$85.5K -432 -10%
MCM
174
MAI Capital Management
Ohio
$785K -$243K -1,226 -24%
EC
175
EntryPoint Capital
New York
$783K +$181K +913 +30%
5 6
7
8 9

LGND Hedge Fund Activity: Q1 2026 in Review

357 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Ligand Pharmaceuticals (LGND) for Q1 2026, worth a combined $4.15B — up 6.8% from $3.89B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new LGND positions and 43 closed out — a net gain of 16 holders — while 133 added to existing stakes and 115 trimmed.

The largest buyer was Invesco, adding an estimated $60.8M. The largest seller was UBS AM, cutting an estimated $29.8M.

  • 357 institutional investors held Ligand Pharmaceuticals (LGND) as of Q1 2026, up from 349 in Q4 2025.
  • Funds reported $4.15B of Ligand Pharmaceuticals stock for Q1 2026, up 6.8% quarter-over-quarter.
  • 59 funds opened new Ligand Pharmaceuticals positions in Q1 2026 and 43 closed out, a net change of +16 holders.
  • The largest Ligand Pharmaceuticals buyer in Q1 2026 was Invesco, an estimated $60.8M added.
  • The largest Ligand Pharmaceuticals seller in Q1 2026 was UBS AM, an estimated $29.8M sold.

Based on aggregated 13F filings for Q1 2026.